Under construction – not a live service
Sign in
Taking peopleNo phase

Implementing Brain Health PRO Across Diverse Settings: A Multi-Site Implementation Study

Key facts

Who runs it
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
434 people, planned
Started
16 Jun 2026
Expected to end
Jun 2028
Type of study
Interventional
Treatments tested
  • Brain Health PRO (BHPRO)
Record updated
13 November 2026

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Sufficient proficiency in English and/or French to complete online assessment and participate in the program
  • Sufficient technological ability to navigate web-based content and participate in the assessment and the program (i.e., access to internet, ability to send and receive a message, ability to complete online assessment)
  • Vision sufficient to participate in the program
  • Aged 50 years and older
  • Classified as being at increased risk based on one of the following:; 5.1. First-degree family history of dementia; 5.2. Formal education at or below 12 years; 5.3. Self-reported 5.3.1. Hypertension 5.3.2. Hypercholesterolemia 5.3.3. High body mass index (>30 kg/m2) 5.3.4. Physical inactivity (less than 20 to 30 minutes of physical activity, 2 times a week)

Who cannot take part

  • Persons with a diagnosis of dementia (based on self-report)
  • Persons who have participated or are currently participating in other studies involving BHPRO

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Brain Health PRO (BHPRO) is a 6-month, web-based dementia-risk-reduction program targeting modifiable risk factors for cognitive decline. This 12-months, multi-site, single-arm, mixed-methods implementation study (Hybrid Type III design) evaluates the real-world adoption, sustainability, and reach of BHPRO across 10-14 partner sites in Canada, spanning seven provinces, including community organizations, clinics, and a public-health agency, with emphasis on rural and underserved communities. Tailored implementation toolkits (BHPRO-ITs), co-developed during Phase 1 using the ERIC taxonomy, are deployed at each site. Implementation outcomes (adoption, sustainability, reach, appropriateness, feasibility) are assessed at provider and organizational levels via online questionnaires and twice-monthly champion meetings. Effectiveness outcomes (dementia literacy, self-efficacy, modifiable risk factor composite, cognition) are collected from end users (adults aged 50+, at risk of dementia) at baseline, 3 months, post-program (6 months), and follow-up (12 months).

The group in the trial

  • BHPRO ImplementationTreatment being tested

    All participating sites implement BHPRO, a six-month, web-based dementia risk reduction program, using tailored implementation toolkits co-developed during Phase 1. Eligible end users at each site are offered access to the intervention. The study employs a single-group assignment without randomization or masking. Implementation is staggered across ten to fourteen Canadian sites, including community organizations, clinical settings, and one public health agency. The primary focus of the study is evaluation of implementation outcomes (adoption, sustainability, reach), while participant-level effectiveness outcomes are measured concurrently.

    Treatment: Brain Health PRO (BHPRO)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Implementing Brain Health PRO - A Dementia Risk Reduction Program - Across Diverse Settings, With Emphasis on Rural and Underserved Communities: Phase 2
Record updated
13 November 2026